This Funding Opportunity Announcement is a Broad Agency Announcement (BAA). It is continuously open for a 5-year period, from October 1, 2017 through September 30, 2022, 11:59 p.m. Eastern Time.

The USAMRMC mission is to provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large.

Next month, we will start a series of workshops for academic scientists. If you always wanted to learn Organ-on-a-Chip techniques, you can now do so, straight from the developers, in just two days. You'll return with two OrganoPlates®, to get you started in the comfort of your own lab.

Our colleague Karlijn Wilschut developed a method for high-content analysis of 3D neurons in the OrganoPlate®, in collaboration with Molecular Devices. This excellent application note is the result.

REGENXBIO Inc. (Nasdaq:RGNX) today announced that Dimension Therapeutics, Inc. (Nasdaq:DMTX) notified REGENXBIO that it has determined that it has received a “superior proposal” as defined in the merger agreement under which REGENXBIO would have acquired Dimension in an all-stock transaction for an implied value of approximately $3.41 per share based on the closing stock price of REGENXBIO stock on August 24, 2017.

CureSearch for Children’s Cancer announced the application launch for a $2 million to $5 million (USD) Catapult Impact Fund Award opportunity. The award will support the advancement of clinical research to improve outcomes for pediatric cancer patients.

Johns Hopkins Technology Ventures kicked off its inaugural cohort of healthcare startups last month with a focus on connected health and fitness. Called M-1 Ventures, a reference to first-year medical students, the accelerator represents a change of strategy for cultivating early stage companies. Although Johns Hopkins previously collaborated with Dreamit Ventures, it was interested in developing an accelerator on its own. To that end it formed regional alliances with the University of Maryland, Village Capital., and the family office of Baltimore-based Under Armour CEO and Chairman Kevin Plank — Plank Industries.

Sisu Global Health is entering product launch phase in a pair of African countries.

The company recently received regulatory clearance to sell its blood transfusion device in Kenya and Ghana, CEO Carolyn Yarina said.

Protenus, the health care industry's most robust, analytics-driven solution for detecting inappropriate activity in the electronic health record, is excited to announce that its Co-Founder and President, Robert Lord, has been selected as a New America Cybersecurity Policy Fellow for the 2017-2018 cohort. This fellowship brings together the world's top cybersecurity leaders from private industry, academia, journalism, the public sector, and the military to envision and build the future of cybersecurity.

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its recently submitted supplemental New Drug Application (sNDA) for lubiprostone (AMITIZA®) in children aged 6 to 17 years with pediatric functional constipation.  The filing has received Priority Review designation from the FDA.

Baltimore has the potential to be a city that is truly hospitable to small business growth, with all the economic benefits of jobs and tax revenue such growth would bring. But for new and established small businesses to thrive, the city needs a financing system with capacity to meet their needs.

Capital is certainly not the only ingredient necessary for successful business growth, but it is a critical input. If companies lack access to appropriate types of capital at critical stages of growth, they are likely to never take off and achieve scale, or even worse, to go out of business or leave Baltimore and relocate where financial support is more readily available, depriving the local economy of jobs and economic growth.

The Washington Business Journal's annual Innovation Awards honor 15 Greater Washington companies, agencies and teams working to keep the metro on the cutting edge in tech, health care, cybersecurity and more.

Health Canada has approved the probiotic Visbiome as a Natural Health Product for treating symptoms of irritable bowel syndrome in adults and children aged older than 5 years, the manufacturer announced.

From catching Pokémon in the real world to donning a virtual reality headset to see and feel what it was like to scale the Berlin Wall before its fall, advancements in immersive media have set the stage for the next digital revolution. The University of Maryland will lead this revolution with the launch of the Mixed/Augmented/Virtual Reality Innovation Center, called MAVRIC, which has been awarded a $500,000 grant from the U.S. Department of Commerce Economic Development Administration (EDA).

Radiology is facing rapid change on many fronts—technology is more complex than ever, more IT tools are being developed to support radiologists and new economic forces are changing the financial dynamics for those working in this important branch of medicine. Despite the challenges, Health Data Management has identified several leaders in the field who are finding ways to exploit new technology to improve the effectiveness and efficiency of the radiology department.

Building on a 30-year relationship with Children's National, Costco Wholesale has pledged $25 million to ensure that children in the Washington area will continue to have access to expert pediatric care. In recognition of their longstanding support, Children's National is naming the hospital's main atrium the Costco Wholesale Atrium.

Six companies presenting innovative medical device solutions that address significant unmet needs in pediatric health were awarded a total of $250,000 in grant money yesterday

The creators of six innovative pediatric devices received a total $250,000 in prize money at the fifth annual Pediatric Device Innovation Symposium, co-located this year at AdvaMed’s The MedTech Conference in San Jose, Calif.

The DOD SBIR 17.3 and STTR 17.C Broad Agency Announcement (BAA) topics are now OPEN for proposal submission! Begin by creating an account - you can then view topics, ask questions through the SITIS Q&A system, and start your proposal.

This BAA will officially CLOSE on October 25, at 8:00 PM E.T.!

Let me be clear: I believe strongly in the need for substantive, consumer-centric transformation of the health care system and have been a long-term proponent of the power of entrepreneurs to catalyze and drive these difficult changes.

Governor Terry McAuliffe announced twelve Virginia companies have been selected to participate in the Virginia Economic Gardening Pilot Program, and two are in Harrisonburg.

"Economic gardening" is encouraging growth in businesses that are already locally established, or second stage companies.

Advances in biotechnology and synthetic biology over the past decade have the potential to address important societal challenges in food, energy, and medicine. But these technological advances come with the potential for their deliberate or accidental misuse, warranting the development of approaches to help prevent the creation of biothreats.

Everyone knows that entrepreneurship is risky. In light of recent news about a possible sale or merger of 1776, I wonder if the greater Washington region is indeed remembering what everyone knows. 

The MdBio Foundation, a non-profit that provides STEM education and workforce development to underserved communities, is celebrating its 16th school year of delivering innovative, hands-on science, technology, engineering and math (STEM) education to students aboard mobile laboratories. During the 2017-18 school year, the foundation will debut its new Mobile eXploration Lab (MXLab), the largest mobile laboratory of its kind in the U.S., at high schools across the state of Maryland, and begin offering a new mobile program for middle schools in Washington, D.C., through a $1.36 million grant from the Verizon Foundation.

EAGB has moved to the Silo Point building in Locust Point! Please be sure to update your records with our new address.

1200 Steuart St, Suite C1B Baltimore, MD 21230

Our completely new site is up and running! Thank you for your patience as we rebooted.

CLICK HERE TO EXPLORE

WorkSource Montgomery has grown exponentially in its first year, and we are happy to have new staff, a new address to our corporate headquarters and the opportunity to serve our businesses and talent each day. To celebrate a year of accomplishments, let’s take a look back at where we started.

In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup.

Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.

The European Commission approved Tecentriq, also known as atezolizumab, as a monotherapy for locally advanced or metastatic non-small cell lung cancer (NSCLC) after patients have been treated with chemotherapy.

The market opportunity in health care is huge, and Apple sees health care and wellness as a core part of its app, services, and wearables strategies. Now the company is aiming to become your personal health record, jumping into research, medical devices, and more.

Startups and entrepreneurs involved with Johns Hopkins Technology Ventures secured hundreds of patents and invention disclosures, and brought in millions of dollars in funding in fiscal year 2017.

Please join the BioPark's Monthly Networking Event. Mingle with BioPark tenants, and UMB faculty and staff.

Host:  UM BioPark & Wexford Science + Technology

Location:  UM BioPark On the Patio (weather permitting) 801 W. Baltimore Street Baltimore  Maryland  21201

Time:  September 27, 2017, 5:00pm to 6:30pm

An Annapolis medical technology company is moving its headquarters to The LaunchPort, a device manufacturing accelerator set to be housed at the City Garage startup hub in Port Covington.

Vixiar Medical spun out of research at Johns Hopkins. Three years later, the startup will officially be a Baltimore company.

Contrary Capital, a university-focused venture capital fund, officially launched on Monday at 55 colleges across the country, including Hopkins. Contrary works with 100 students to find start-ups and projects within their university communities in which they can invest.

The Cedars-Sinai accelerator, managed by Techstars, kicked off its third class of healthcare startups this month. some of which are more mature than previous cohorts with a seed stage round behind them. Whittled down from roughly 600 applicants, the 10 companies are seeking to improve the patient experience, offer more personalized care plans for cancer treatment, triage faster and make blood sample collection less painful. Their technologies span artificial intelligence, voice recognition, microfluidics, and natural language processing.

Larger medtech companies have traditionally shied away from investing in the pediatric market, but the landscape is changing. In the last year alone, we witnessed the passage of the 21st Century Cures Act and the signing of the FDA Reauthorization Act (FDARA 2017) into law. The industry is ripe for innovation and these legislative advances present new opportunities to connect innovators with the investment community.

One week until Beta City! Join Betamore + Sagamore Ventures on September 28 for Maryland's annual celebration of entrepreneurship + technology. Beta City brings together Baltimore's greatest minds for a day full of pitches, startup demos and a celebration of our growing community.